Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges |
Autore | Diebold Yolanda |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (207 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
MPC polymer
dry eye ocular surface lacrimal fluid mucin 3D bioprinting cornea retina ophthalmology tissue regeneration electrospinning conjunctiva decellularized tissue matrix small intestinal submucosa urinary bladder matrix polycaprolactone fiber tissue engineering stratification conjunctival epithelial cells hydrogel keratoplasty scaffold collagen advanced therapy medicinal product ATMP cell therapy gene therapy eye ocular regulatory marketing authorization double-crosslinking carbodiimide glutaraldehyde sodium metabisulfite sodium borohydride EDC/NHS stem cells retinal diseases optic nerve diseases cell replacement cell sources advanced therapies ocular mucosa blindness CLET limbal niche limbal stem cell LSCD mesenchymal stem cell transplantation MSCT corneal limbus decellularized xenograft recellularization mesenchymal stem cells |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Advanced Therapy Medicinal Products for Eye Diseases |
Record Nr. | UNINA-9910557675503321 |
Diebold Yolanda | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Hurdles for Phage Therapy (PT) to Become a Reality |
Autore | Brüssow Harald |
Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
Descrizione fisica | 1 electronic resource (484 p.) |
Soggetto non controllato |
alginate
abortive infection bacterial resistance bacteriophages ATMP MALDI-MS adaptation Bacteriophage horizontal gene transfer adaptive immunity co-evolution Listeria ivanovii personalised medicines pH stability phage-human host interaction vB_SauM-fRuSau02 antimicrobial resistance phagodisinfection biofilm capsule depolymerase animal model phage cocktails Enterococcus cases report zoonosis resistance magistral formula experimental therapy Belgium phage therapy E. faecalis nontraditional antibacterial industrial phage application Democratic Republic of the Congo OrthoMCL Germany high-throughput sequencing antimicrobial infection antibiotic therapy Kayvirus phages Twortlikevirus bacterial disease human host Pseudomonas aeruginosa phage multidrug-resistant bacteria bacterial infection Salmonella Typhi rhamnopolysaccharide compassionate use crop production compounding pharmacy antimicrobial resistance (AMR) best practices bacteriophage efficacy phage sensitivity antibiotic-resistance antibiotic lysins PTMP Escherichia coli typhoid fever patent landscape phage preparation innate immunity anti-phage antibodies immunology Staphylococcus aureus global health clinical trial adsorption Brussels phage-resistance Galleria mellonella science communication history of science virus-host interactions foodborne illness prophage resistance management biofilms IND immunomodulation frequency of resistance capsule gastrointestinal tract phage-host interactions disinfection production bacteriophage therapy bacteriophage Staphylococcus magistral preparation extended-spectrum beta lactamases (ESBL) Viral proteins antibiotic resistance genomics phage biocontrol therapy target selection viral genomes evolution pharmaceutical paradigm shift personalized medicine pharmaceutical legislation food safety regulation virulence developing countries infectious disease regulatory framework sustainable agriculture Klebsiella pneumoniae |
ISBN | 3-03921-392-X |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Hurdles for Phage Therapy |
Record Nr. | UNINA-9910367566603321 |
Brüssow Harald | ||
MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|